comparemela.com
Home
Live Updates
Abbotts (ABT) Q4 Earnings and Revenues Beat Estimates : comparemela.com
Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates
Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.
Related Keywords
China ,
Boston ,
Massachusetts ,
United States ,
India ,
Russia ,
Henry Schein ,
Abbott Laboratories ,
Henry Schein Inc ,
Zacks Investment Research ,
Core Laboratory Diagnostics ,
Boston Beer Company ,
Research Sheraz Mian ,
Nvidia ,
Pharmaceuticals Division ,
Healthcare Services Inc ,
Hologic Inc ,
Zacks Consensus Estimate ,
Established Pharmaceuticals Division ,
Medical Devices ,
Freestyle Libre ,
Laboratories Price ,
Adult Nutrition ,
Laboratory Diagnostics ,
Molecular Diagnostics ,
Vcare Diagnostics ,
Diabetes Care ,
Within Adult Nutrition ,
Zacks Rank ,
Strong Buy ,
Best Pick ,
Zack Stocks Set ,
Our Top Stock ,
Zacks Investment ,
Stocks ,
Finance ,
comparemela.com © 2020. All Rights Reserved.